Skip to main content
. 2021 May 18;2021(5):CD007579. doi: 10.1002/14651858.CD007579.pub3

Koju 2015.

Study characteristics
Methods RCT
Participants 50 women for elective CD under spinal
Interventions Intervention: 5‐HT3antagonist (A)
  • Ondansetron 4 mg, IV before spinal

  • N = 25


Comparison: placebo
  • Normal saline.

  • N = 25

Outcomes PONV on 4 point scale every 15 in for 4 hours, then at 4, 8 and 24 hours
Notes Setting: Patan Hospital, Patan, Lalitpur, Nepal.
Dates: August 2008 to January 2009
Funding source: not reported.
Declaration of interest: state no conflict of interest both financial and non‐financial.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Unspecified:quote: "randomly allocated"
Allocation concealment (selection bias) Unclear risk Only reports that women and clinicians unaware of allocation
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Nurse drew up drugs, Dr administered
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No dropouts
Selective reporting (reporting bias) Unclear risk Resident (junior) doctors performed data collection
Other bias Unclear risk No baseline imbalance